Advancements in Cancer Stem Cell Isolation and Characterization
Overview
Affiliations
Occurrence of stem cells (CSCs) in cancer is well established in last two decades. These rare cells share several properties including presence of common surface markers, stem cell markers, chemo- and radio- resistance and are highly metastatic in nature; thus, considered as valuable prognostic and therapeutic targets in cancer. However, the studies related to CSCs pave number of issues due to rare cell population and difficulties in their isolation ascribed to common stem cell marker. Various techniques including flow cytometry, laser micro-dissection, fluorescent nanodiamonds and microfluidics are used for the isolation of these rare cells. In this review, we have included the advance strategies adopted for the isolation of CSCs using above mentioned techniques. Furthermore, CSCs are primarily found in the core of the solid tumors and their microenvironment plays an important role in maintenance, self-renewal, division and tumor development. Therefore, in vivo tracking and model development become obligatory for functional studies of CSCs. Fluorescence and bioluminescence tagging has been widely used for transplantation assay and lineage tracking experiments to improve our understanding towards CSCs behaviour in their niche. Techniques such as Magnetic resonance imaging (MRI) and Positron emission tomography (PET) have proved useful for tracking of endogenous CSCs which could be helpful in their identification in clinical settings.
Nanodiamonds in biomedical research: Therapeutic applications and beyond.
Alexander E, Leong K PNAS Nexus. 2024; 3(5):pgae198.
PMID: 38983694 PMC: 11231952. DOI: 10.1093/pnasnexus/pgae198.
Cancer stem cells: advances in knowledge and implications for cancer therapy.
Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z Signal Transduct Target Ther. 2024; 9(1):170.
PMID: 38965243 PMC: 11224386. DOI: 10.1038/s41392-024-01851-y.
Tayhan S Med Oncol. 2024; 41(7):185.
PMID: 38910198 PMC: 11194218. DOI: 10.1007/s12032-024-02423-4.
Liu S, Wen H, Li F, Xue X, Sun X, Li F J Transl Med. 2024; 22(1):468.
PMID: 38760813 PMC: 11101349. DOI: 10.1186/s12967-024-05276-7.
Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells.
Lee J, Lee H J Ginseng Res. 2024; 48(3):266-275.
PMID: 38707642 PMC: 11068999. DOI: 10.1016/j.jgr.2024.03.003.